News Focus
News Focus
icon url

Ortiz

10/21/21 2:57 PM

#333467 RE: georgejjl #333462

And that does not include the other millions taking it as prophylaxis.
icon url

tredenwater2

10/21/21 3:29 PM

#333480 RE: georgejjl #333462

Keep up the good work Georgeii.
icon url

BIOChecker4

10/21/21 4:47 PM

#333493 RE: georgejjl #333462

How would Anavex be able to sell Blarcamesine for $3,650 a year ($10 a day) for AD and $200,000-$600,000 a year for Rett? Please provide any example where the identical approved marketed drug is priced so low for one indication and so high for another.